Search Results | DrugBank Online

Displaying drugs 13951 - 13975 of 14942 in total

ECT204

ECT204 is an autologous T-cell therapy whereby T cells are genetically modified to target tumor-specific antigens.

Investigational

ST266

ST266 is an amniotic membrane-derived cellular cytokine solution.

Investigational

VGB-R04

VGB-R04 is an adeno-associated viral vector delivering human FIX Padua gene.

Investigational

CTX130

CTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.

Investigational

Allogeneic natural killer cells

Investigational

AVR-RD-05 is a gene therapy comprising genetically modified autologous stem cells transduced ex vivo with a lentiviral vector encoding the human iduronate-2-sulfatase (IDS) enzyme. It is under investigation for the treatment of Hunter Syndrome (Mucopolysaccharidosis Type II, MPSII).

Investigational

MaaT013

MaaT013 is an allogeneic fecal microbiota therapy. It is being investigated for the treatment of Graft-Versus-Host Disease.

Investigational

ATIR101

ATIR101 is a haploidentical, naïve cell-enriched T-cell therapy.

Investigational

Allogeneic human pancreatic islets of Langerhans

Investigational

ssCART-19 cells

ssCART-19 cells consist of autologous anti-CD19 Chimeric Antigen Receptors (CAR)-T cells expressing a short hairpin RNA (shRNA) against interleukin-6 (IL-6).

Investigational

Epidermal Growth Factor Receptor variant III (EGFRvIII) chimeric antigen receptor T cells

Investigational

Autologous CD4+CD25hiFoxP3+regulatory T cells

Investigational

Avoplacel

Avoplacel (PLX-R18) is an allogeneic cell therapy under investigation for the treatment of acute radiation syndrome.

Investigational

Ex vivo expanded autologous human corneal epithelial cells containing stem cells

Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) is a stem cell therapy used to treat limbal stem cell deficiencies.

Investigational